Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$48.70
-1.54%
Mkt Cap $2.87B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $195.16M | $211.57M | +8.41% | $0.28 | $0.92 | +228.57% | — | — |
| Q4 2025 Nov 4, 2025 | $194.73M | $192.10M | -1.35% | $0.82 | $1.01 | +23.17% | — | — |
| Q3 2025 Aug 5, 2025 | $168.23M | $165.45M | -1.65% | $0.47 | $0.91 | +93.62% | — | — |
| Q2 2025 May 6, 2025 | $147.94M | $149.82M | +1.28% | $0.38 | $0.42 | +10.53% | — | — |
| Q1 2025 Feb 25, 2025 | $155.25M | $174.16M | +12.18% | $0.46 | $0.75 | +63.04% | — | — |
| Q4 2024 Nov 4, 2024 | $154.51M | $175.69M | +13.70% | $0.39 | $1.06 | +171.79% | — | — |
| Q3 2024 Aug 6, 2024 | $148.85M | $168.32M | +13.08% | $0.31 | $0.36 | +16.13% | — | — |
| Q2 2024 May 8, 2024 | $145.83M | $143.64M | -1.50% | $0.38 | $0.26 | -31.58% | — | — |
| Q1 2024 Feb 27, 2024 | $155.03M | $164.31M | +5.99% | $0.41 | $0.02 | -95.12% | — | — |
| Q4 2023 Nov 8, 2023 | $155.27M | $153.88M | -0.90% | $0.13 | -$0.29 | -323.08% | — | — |
| Q3 2023 Aug 8, 2023 | $143.66M | $135.56M | -5.64% | $0.23 | -$0.02 | -108.70% | — | — |
| Q2 2023 May 9, 2023 | $139.02M | $153.76M | +10.61% | $0.17 | $0.29 | +70.59% | — | — |
| Q1 2023 Feb 28, 2023 | $180.33M | $167.33M | -7.21% | $0.68 | $0.43 | -36.76% | — | — |
| Q4 2022 Nov 8, 2022 | $172.48M | $177.35M | +2.83% | $0.36 | $0.03 | -91.67% | — | — |
| Q3 2022 Aug 4, 2022 | $164.13M | $170.05M | +3.61% | $0.29 | $0.14 | -51.72% | — | — |
| Q2 2022 Apr 13, 2022 | $153.91M | $152.51M | -0.91% | $0.24 | $0.04 | -83.33% | — | — |
| Q1 2022 Feb 28, 2022 | $148.38M | $159.05M | +7.19% | $0.24 | $0.04 | -81.34% | — | — |
| Q4 2021 Nov 3, 2021 | $118.11M | $148.46M | +25.70% | $0.23 | $0.40 | +73.91% | — | — |
| Q3 2021 Aug 4, 2021 | $134.87M | $141.33M | +4.79% | $0.20 | $0.43 | +115.00% | — | — |
| Q2 2021 May 5, 2021 | $129.42M | $130.93M | +1.17% | $0.24 | $0.11 | -54.17% | — | — |